Filing Details
- Accession Number:
- 0001209191-14-021855
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-19 16:20:00
- Reporting Period:
- 2014-03-03
- Filing Date:
- 2014-03-19
- Accepted Time:
- 2014-03-19 16:20:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1254419 | Medassets Inc | MDAS | Services-Prepackaged Software (7372) | 510391128 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1516879 | O Charles Garner | 100 North Point Center East Suite 200 Alpharetta GA 30022 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-03 | 746 | $0.00 | 3,913 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-03 | 746 | $24.19 | 3,167 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2014-03-03 | 2,000 | $0.00 | 2,000 | $16.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,002 | 2018-05-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Restricted Stock | 72,000 | Direct | |
| Restricted Stock | 3,489 | Direct | |
| Restricted Stock | 2,982 | Direct | |
| Restricted Stock | 3,303 | Direct | |
| Restricted Stock | 6,369 | Direct | |
| Restricted Stock | 9,554 | Direct | |
| Restricted Stock | 9,554 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.98 to $24.22, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted.
- The reporting person was granted these SSARs on May 9, 2011. The SSARs vest equally (over the course of 60 months) beginning on May 1, 2011 such that 100% of the SSARs will be fully vested on April 1, 2016.
Billionaire Hedge Funds
